D

Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192

Watchlist Manager
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Watchlist
Price: 45.34 CNY -1.82% Market Closed
Market Cap: 18.8B CNY
Have any thoughts about
Dizal Jiangsu Pharmaceutical Co Ltd?
Write Note

Dizal Jiangsu Pharmaceutical Co Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dizal Jiangsu Pharmaceutical Co Ltd
Accrued Liabilities Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
D
Dizal Jiangsu Pharmaceutical Co Ltd
SSE:688192
Accrued Liabilities
ÂĄ57.5m
CAGR 3-Years
28%
CAGR 5-Years
36%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Accrued Liabilities
ÂĄ2.6B
CAGR 3-Years
49%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Accrued Liabilities
ÂĄ268.5m
CAGR 3-Years
37%
CAGR 5-Years
39%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Accrued Liabilities
ÂĄ164.1m
CAGR 3-Years
50%
CAGR 5-Years
30%
CAGR 10-Years
19%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Accrued Liabilities
ÂĄ325.2m
CAGR 3-Years
-23%
CAGR 5-Years
21%
CAGR 10-Years
45%
Imeik Technology Development Co Ltd
SZSE:300896
Accrued Liabilities
ÂĄ116.1m
CAGR 3-Years
52%
CAGR 5-Years
49%
CAGR 10-Years
N/A

See Also

What is Dizal Jiangsu Pharmaceutical Co Ltd's Accrued Liabilities?
Accrued Liabilities
57.5m CNY

Based on the financial report for Dec 31, 2023, Dizal Jiangsu Pharmaceutical Co Ltd's Accrued Liabilities amounts to 57.5m CNY.

What is Dizal Jiangsu Pharmaceutical Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
36%

Over the last year, the Accrued Liabilities growth was 14%. The average annual Accrued Liabilities growth rates for Dizal Jiangsu Pharmaceutical Co Ltd have been 28% over the past three years , 36% over the past five years .

Back to Top